|
| (1S,2S,3R,5S)-PinanediolN-BOC-L-phenylalanine-L-leucine boronate Basic information |
Product Name: | (1S,2S,3R,5S)-PinanediolN-BOC-L-phenylalanine-L-leucine boronate | Synonyms: | (1S,2S,3R,5S)-PinanediolN-BOC-L-phenylalanine-L-leucine boronate;tert-butyl 4-(2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)Methyl)-benzoyl)piperazin-1-carboxylate;Bortezomib Impurity 53;Carbamic acid, N-[(1S)-2-[[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-, 1,1-dimethylethyl ester | CAS: | 1187479-72-6 | MF: | C29H45BN2O5 | MW: | 512.49 | EINECS: | | Product Categories: | | Mol File: | 1187479-72-6.mol | |
| (1S,2S,3R,5S)-PinanediolN-BOC-L-phenylalanine-L-leucine boronate Chemical Properties |
Boiling point | 635.7±55.0 °C(Predicted) | density | 1.10±0.1 g/cm3(Predicted) | pka | 11.39±0.46(Predicted) |
| (1S,2S,3R,5S)-PinanediolN-BOC-L-phenylalanine-L-leucine boronate Usage And Synthesis |
Uses | N-[(1S)-2-[[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-Carbamic Acid 1,1-Dimethylethyl Ester is an intermediate in the synthesis of bortezomib (B675700).Bortezomib is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. |
| (1S,2S,3R,5S)-PinanediolN-BOC-L-phenylalanine-L-leucine boronate Preparation Products And Raw materials |
|